TY - JOUR
T1 - Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals
AU - Carletto, A.
AU - Cicchetti, Americo
AU - Coretti, Silvia
AU - Moramarco, Vito
AU - Ruggeri, Matteo
PY - 2019
Y1 - 2019
N2 - The aim of this paper is to provide an empirical framework based on a discrete-time Markov chain to assess the costs and benefits of Performance Based Agreements (PBAs) for the reimbursement of pharmaceuticals. We provide an empirical testing using a case study referring to a treatment recently approved for reimbursement in Italy. The implementation of this framework is challenging for the agencies dealing with pricing and reimbursement decisions given the uncertainty associated with the treatment effectiveness and safety. On the other hand, empirical evidence shows that the awareness of the expected costs associated with different reimbursement schemes is necessary to inform decision-makers.
AB - The aim of this paper is to provide an empirical framework based on a discrete-time Markov chain to assess the costs and benefits of Performance Based Agreements (PBAs) for the reimbursement of pharmaceuticals. We provide an empirical testing using a case study referring to a treatment recently approved for reimbursement in Italy. The implementation of this framework is challenging for the agencies dealing with pricing and reimbursement decisions given the uncertainty associated with the treatment effectiveness and safety. On the other hand, empirical evidence shows that the awareness of the expected costs associated with different reimbursement schemes is necessary to inform decision-makers.
KW - Cost-benefit Analysis
KW - Markov models
KW - Performance Based Agreements
KW - Pharmaceutical policy
KW - Pricing and Reimbursement
KW - Cost-benefit Analysis
KW - Markov models
KW - Performance Based Agreements
KW - Pharmaceutical policy
KW - Pricing and Reimbursement
UR - http://hdl.handle.net/10807/134691
U2 - 10.1007/s40821-018-0107-y
DO - 10.1007/s40821-018-0107-y
M3 - Article
SN - 1309-4297
VL - 9
SP - 89
EP - 101
JO - Eurasian Business Review
JF - Eurasian Business Review
ER -